Literature DB >> 24549503

Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance.

I K Tulloch1, L Afanador, L Baker, D Ordonez, H Payne, I Mexhitaj, E Olivares, A Chowdhury, J A Angulo.   

Abstract

Methamphetamine (METH) causes significant loss of some striatal projection and interneurons. Recently, our group reported on the proliferation of new cells 36 h after METH and some of the new cells survive up to 12 weeks (Tulloch et al., Neuroscience 193:162-169, 2011b). We hypothesized that some of these cells will differentiate and express striatal neuronal phenotypes. To test this hypothesis, mice were injected with METH (30 mg/kg) followed by a single BrdU injection (100 mg/kg) 36 h after METH. One week after METH, a population of BrdU-positive cells expressed the neuronal progenitor markers nestin (18 %) and β-III-tubulin (30 %). At 8 weeks, 14 % of the BrdU-positive cells were also positive for the mature neuron marker, NeuN. At 12 weeks, approximately 7 % of the BrdU-positive cells co-labeled with ChAT, PV or DARPP-32. We measured motor coordination on the rotarod and psychomotor activity in the open-field. At 12 weeks, METH-injected mice exhibited delayed motor coordination deficits. In contrast, open-field tests revealed that METH-injected mice compared to saline mice displayed psychomotor deficits at 2.5 days but not at 2 or more weeks after METH. Taken together, these data demonstrate that some of the new cells generated in the striatum differentiate and express the phenotypes of striatal neurons. However, the proportion of these new neurons is low compared to the proportion that died by apoptosis 24 h after the METH injection. More studies are needed to determine if the new neurons are functional.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549503      PMCID: PMC4071120          DOI: 10.1007/s12640-014-9456-1

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  59 in total

Review 1.  Adult neurogenesis: a compensatory mechanism for neuronal damage.

Authors:  H G Kuhn; T D Palmer; E Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001-08       Impact factor: 5.270

2.  Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice.

Authors:  Maria Cristina Marrone; Silvia Marinelli; Filippo Biamonte; Flavio Keller; Carmelo Alessio Sgobio; Martine Ammassari-Teule; Giorgio Bernardi; Nicola B Mercuri
Journal:  Eur J Neurosci       Date:  2006-10       Impact factor: 3.386

3.  Two independent behavioral dimensions in open-field performance.

Authors:  A E Whimbey; V H Denenberg
Journal:  J Comp Physiol Psychol       Date:  1967-06

4.  Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.

Authors:  Cindy Achat-Mendes; Syed F Ali; Yossef Itzhak
Journal:  Neuropsychopharmacology       Date:  2005-06       Impact factor: 7.853

5.  Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method.

Authors:  X Deng; Y Wang; J Chou; J L Cadet
Journal:  Brain Res Mol Brain Res       Date:  2001-09-10

6.  Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.

Authors:  A J Eisch; J F Marshall
Journal:  Synapse       Date:  1998-12       Impact factor: 2.562

7.  Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.

Authors:  Yuko Kataoka; Paul S A Kalanithi; Heidi Grantz; Michael L Schwartz; Clifford Saper; James F Leckman; Flora M Vaccarino
Journal:  J Comp Neurol       Date:  2010-02-01       Impact factor: 3.215

8.  Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study.

Authors:  Ruth Salo; Stefan Ursu; Michael H Buonocore; Martin H Leamon; Cameron Carter
Journal:  Biol Psychiatry       Date:  2009-01-12       Impact factor: 13.382

9.  Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.

Authors:  Irina N Krasnova; Amber B Hodges; Bruce Ladenheim; Raina Rhoades; Crystal G Phillip; Angela Cesena; Ekaterina Ivanova; Christine F Hohmann; Jean Lud Cadet
Journal:  Neurosci Res       Date:  2009-06-24       Impact factor: 3.304

10.  New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma.

Authors:  Federico Luzzati; Silvia De Marchis; Rosanna Parlato; Simona Gribaudo; Günther Schütz; Aldo Fasolo; Paolo Peretto
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

View more
  7 in total

1.  Decreased Expression of Plasma MicroRNA in Patients with Methamphetamine (MA) Use Disorder.

Authors:  Yan Zhao; Kai Zhang; Haifeng Jiang; Jiang Du; Zong Na; Wei Hao; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-23       Impact factor: 4.147

2.  Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Authors:  Bryan A Killinger; Anna Moszczynska
Journal:  J Neurochem       Date:  2015-12-10       Impact factor: 5.372

3.  Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.

Authors:  Michael C Edler; Asma B Salek; Darryl S Watkins; Harjot Kaur; Cameron W Morris; Bryan K Yamamoto; Anthony J Baucum
Journal:  ACS Chem Neurosci       Date:  2018-06-01       Impact factor: 4.418

Review 4.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

5.  Does Repeated Methamphetamine Exposure at Different Regimens Cause Parkinsonian-Like Behavior in Rats?

Authors:  Neda Valian; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

6.  Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats.

Authors:  Effat Ramshini; Shahriar Dabiri; Shokouh Arjmand; Gholamreza Sepehri; Mohammad Khaksari; Meysam Ahmadi-Zeidabadi; Mohammad Shabani
Journal:  Addict Health       Date:  2017

7.  Increased expression of plasma hsa-miR-181a in male patients with heroin addiction use disorder.

Authors:  Wenjin Xu; Ming Zhao; Zi Lin; Haixiong Liu; Hong Ma; Qingxiao Hong; Donghui Gui; Jiying Feng; Yue Liu; Wenhua Zhou; Huifen Liu
Journal:  J Clin Lab Anal       Date:  2020-08-03       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.